7.11
price up icon2.60%   0.18
after-market Dopo l'orario di chiusura: 7.15 0.04 +0.56%
loading

Corvus Pharmaceuticals Inc Borsa (CRVS) Ultime notizie

pulisher
11:19 AM

Will Corvus Pharmaceuticals Inc. stock go up soon2025 AllTime Highs & Low Drawdown Investment Ideas - newser.com

11:19 AM
pulisher
11:14 AM

What technical models suggest about Corvus Pharmaceuticals Inc.’s comebackWatch List & Free Expert Verified Stock Movement Alerts - newser.com

11:14 AM
pulisher
09:03 AM

Should you hold or exit Corvus Pharmaceuticals Inc. nowPortfolio Update Report & Daily Profit Focused Stock Screening - newser.com

09:03 AM
pulisher
09:03 AM

Using RSI to spot recovery in Corvus Pharmaceuticals Inc.July 2025 News Drivers & Entry and Exit Point Strategies - newser.com

09:03 AM
pulisher
08:46 AM

Barclays Initiates Corvus Pharmaceuticals at Overweight With $16 Price Target - MarketScreener

08:46 AM
pulisher
08:36 AM

Barclays Initiates Coverage on CRVS with Overweight Rating | CRV - GuruFocus

08:36 AM
pulisher
06:27 AM

Barclays initiates Corvus Pharmaceuticals stock with Overweight rating - Investing.com

06:27 AM
pulisher
Oct 10, 2025

Corvus Pharmaceuticals Inc.’s volatility index tracking explainedShort Setup & Safe Entry Momentum Stock Tips - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What analysts say about Corvus Pharmaceuticals Inc stockInsider Trading Activity & Free Lightning Fast Capital Gains - earlytimes.in

Oct 10, 2025
pulisher
Oct 10, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Corvus Pharmaceuticals (NASDAQ:CRVS) - MarketBeat

Oct 10, 2025
pulisher
Oct 06, 2025

Detecting support and resistance levels for Corvus Pharmaceuticals Inc.July 2025 Momentum & Verified Momentum Watchlists - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Empirical Financial Services LLC d.b.a. Empirical Wealth Management Invests $672,000 in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat

Oct 06, 2025
pulisher
Oct 05, 2025

Has Corvus Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Reactions & Breakout Confirmation Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-03 06:35:03 - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Measuring Corvus Pharmaceuticals Inc.’s beta against major indicesEarnings Miss & Community Verified Trade Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Chart based exit strategy for Corvus Pharmaceuticals Inc.July 2025 Macro Moves & Advanced Technical Signal Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Candlestick signals on Corvus Pharmaceuticals Inc. stock todayWall Street Watch & Daily Stock Trend Watchlist - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Corvus Pharmaceuticals appoints David Moore to board of directors - Investing.com

Oct 02, 2025
pulisher
Oct 02, 2025

Corvus Pharmaceuticals Appoints David Moore To Board Of Directors - TradingView

Oct 02, 2025
pulisher
Oct 02, 2025

Novo Nordisk EVP David Moore Joins Corvus Board to Advance ITK Inhibitor Platform and Commercial Strategy - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 07:08:07 - newser.com

Oct 01, 2025
pulisher
Sep 28, 2025

What drives Corvus Pharmaceuticals Inc stock priceStock Rotation Strategies & Low Risk Capital Appreciation - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

Is Corvus Pharmaceuticals Inc a good long term investmentRisk-Reward Ratio Analysis & Tap Into the Fastest-Growing Companies - Early Times

Sep 27, 2025
pulisher
Sep 26, 2025

Corvus Pharmaceuticals (NASDAQ:CRVS) Shares Up 6.1%Should You Buy? - MarketBeat

Sep 26, 2025
pulisher
Sep 25, 2025

Are Investors Undervaluing Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) By 37%? - 富途牛牛

Sep 25, 2025
pulisher
Sep 25, 2025

While institutions invested in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) benefited from last week's 12% gain, individual investors stood to gain the most - simplywall.st

Sep 25, 2025
pulisher
Sep 23, 2025

Is Corvus Pharmaceuticals Inc. trending in predictive chart modelsMarket Growth Report & Growth Oriented Trade Recommendations - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

What candlestick patterns are forming on Corvus Pharmaceuticals Inc.Weekly Profit Report & Free Daily Entry Point Trade Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is Corvus Pharmaceuticals Inc. forming a reversal patternMarket Trend Report & Reliable Intraday Trade Plans - newser.com

Sep 22, 2025
pulisher
Sep 21, 2025

How to integrate Corvus Pharmaceuticals Inc. into portfolio analysis toolsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com

Sep 21, 2025
pulisher
Sep 20, 2025

Moving Averages: Is Corvus Pharmaceuticals Inc undervalued by DCF analysis2025 Performance Recap & Risk Controlled Daily Trade Plans - خودرو بانک

Sep 20, 2025
pulisher
Sep 20, 2025

Using data models to predict Corvus Pharmaceuticals Inc. stock movement2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

How to manage a losing position in Corvus Pharmaceuticals Inc.Quarterly Trade Summary & Fast Entry High Yield Tips - newser.com

Sep 20, 2025
pulisher
Sep 20, 2025

Will Corvus Pharmaceuticals Inc stock hit new highs in YEAR2025 Growth vs Value & Accurate Technical Buy Alerts - khodrobank.com

Sep 20, 2025
pulisher
Sep 19, 2025

Layoff Watch: Is Corvus Pharmaceuticals Inc undervalued by DCF analysisMarket Performance Report & Low Drawdown Investment Ideas - khodrobank.com

Sep 19, 2025
pulisher
Sep 19, 2025

Visual analytics tools that track Corvus Pharmaceuticals Inc. performanceQuarterly Trade Report & Daily Market Momentum Tracking - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Published on: 2025-09-20 03:21:59 - خودرو بانک

Sep 19, 2025
pulisher
Sep 19, 2025

Has Corvus Pharmaceuticals Inc. found a price floorPrice Action & Daily Stock Momentum Reports - newser.com

Sep 19, 2025
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):